Kan digital teknologi revolutionere Parkinson-behandlingen? 

Nye wearables og digitale løsninger skyder frem i en rasende fart – fra infrarøde cueing-systemer og avancerede smartwatches til sensorer, der kan registrere motoriske og non-motoriske symptomer i realtid. Men hvad kan vi egentlig bruge dem til i klinikken?

Det diskuterer Bo og Karen i dagens episode. Og ser nærmere på, hvordan wearables kan give et mere nuanceret billede af sygdommens udvikling, hvorfor nogle patienter elsker teknologien – mens andre er skeptiske – og hvordan digitale løsninger måske en dag kan hjælpe med både diagnosticering, monitorering og behandling.

Værter:

• Bo Biering-Sørensen, Overlæge, MPG Spasticitetsklinikken, Klinik for Bevægeforstyrrelser, Smerteklinikken/ CRPS klinikken, Afdeling for Hjerne- og Nervesygdomme, Rigshospitalet Glostrup.
• Karen Østergaard, Neurolog, dr.med., Forskningsformidler v/Parkinsonforeningen, Speciallægekonsulent 

Arbejdsgruppen: Bo Biering Sørensen, Karen Østergaard, Helle Witt,  Amalie Djurhuus og Michelle Gjørlund. Tilrettelæggelse, redigering & lyddesign: Anette Lilleøre og  Mathias Lyhne med hjælp fra Anders Guldberg og Sissel Ørbæk. Produceret af podcast bureauet hearHEAR. Udgivet af AbbVie | DK-NEUP-250009 - | 1. version d. 7. august 2025


Links & referencer: 

1. Papapetropoulos SS. Patient diaries as a clinical endpoint in Parkinson’sdisease clinical trials. CNS Neurosci Ther. 2012 May;18(5):380–7.
2. Hillel I et al. Is every-day walking in older adults more analogous to dual-taskwalking or to usual walking? Elucidating the gaps between gait performance inthe lab and during 24/7 monitoring. Eur Rev Aging Phys Act Off J Eur GroupRes Elder Phys Act. 2019;16:6.
3. Khodakarami H et al. The Use of Data from the Parkinson’s KinetiGraph toIdentify Potential Candidates for Device Assisted Therapies. Sensors. 2019May 15;19(10):2241.
4. Abbadessa G et al. Digital therapeutics in neurology. J Neurol. 2022Mar;269(3):1209–24.
5. Sun YM et al. Digital biomarkers for precision diagnosis and monitoring inParkinson’s disease. NPJ Digit Med. 2024 Aug 21;7(1):218
6. Janssen Daalen JM et al. Digital biomarkers for non-motor symptoms inParkinson’s disease: the state of the art. Npj Digit Med. 2024 Jul 11;
7(1):186.7. di Biase L et al. Machine learning and wearable sensors for automatedParkinson's disease diagnosis aid: a systematic review. J Neurol. 2024Oct;271(10):6452-6470.
8. Three neurologists from hospital clinics and three from private practice agreedto participate, providing a diverse range of perspectives. Three public healthgraduate students from Copenhagen University, CPU, conducted theinterviews.
9. Rodríguez-Martín D et al. Dispositivos comerciales para la monitorización desíntomas en la enfermedad de Parkinson: beneficios, limitaciones y tendencias[Commercial devices for monitoring symptoms in
10. Cox E et al. Devices for remote continuous monitoring of people withParkinson's disease: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2024 Jul;28(30):1-187
11. Sica M et al. Continuous home monitoring of Parkinson's disease using inertialsensors: A systematic review. PLoS One. 2021 Feb 4;16(2):e0246528.
12. Lee J et al. Use of Mobile Apps for Self-care in People With Parkinson Disease:Systematic Review. JMIR Mhealth Uhealth. 2022 Jan 21;10(1):e33944. doi:10.2196/33944. PMID: 35060910; PMCID: PMC8817212.
13. Yasmine M. Kehnemouyi et al. Emerging wearable technologies formultisystem monitoring and treatment of Parkinson’s disease: a narrativereview. Frontiers in Network Physiology 13 February 2024.
14. Heinz Reichmann et al.The use of wearables for the diagnosis and treatment ofParkinson’s disease. Journal of Neural Transmission (2023) 130:783–791
15. Chao Gao et al. Freezing of gait in Parkinson’s disease: pathophysiology, riskfactors and treatments. Translational Neurodegeneration (2020) 9:12.
16. Lazzaro di Biase et al. Gait Analysis in Parkinson’s Disease: An Overview ofthe Most Accurate Markers for Diagnosis and Symptoms Monitoring. Sensors2020, 20, 3529
17. Wolf-Julian Neumann et al. From Experimental Evidence Toward PracticalImplementation PhD4. Movement Disorders, Vol. 38, No. 6, 2023
18. Pfeifer KJ et al. Clinical Efficacy and Dosing of Vibrotactile Coordinated ResetStimulation in Motor and Non-motor Symptoms of Parkinson’s Disease: AStudy Protocol. Front Neurol 2021 Nov 18;12:758481
19. Thomsen TH et al. Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson's Disease: An Observational
Feasibility Study. Parkinsons Dis. 2024 Apr 8;2024:5522824.
20. Thomsen TH et al. Empower-PD: Development of A SelfManagement Programin Empowering People with Parkinson’s Disease - A Qualitative Study Using ACo-Creation Framework. Int J Nurs Health Care Res 7:1541 (2024)